Applied Testing News Today

Ghana-based precision medicine company Revna Biosciences has received historic approval from the Food and Drugs Authority of Ghana to use the NeuMoDx 96 diagnostics platform supplied by the global... | June 21, 2023

Venlo, the Netherlands, June 15, 2023 -- QIAGEN welcomes the publication of a new, systematic review highlighting the unique value of its proprietary tuberculosis testing technology. The study... | June 15, 2023

Venlo, the Netherlands, and Redwood City, California, June 13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced that its variant interpretation and reporting software, QIAGEN

The Business Research Company’s Nucleic Acid Isolation And Purification Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

Venlo, the Netherlands, April 24, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its QIAstat-Dx syndromic testing solution is expected to be available

Venlo, the Netherlands, April 24, 2023 -- QIAGEN announced today that its QIAstat-Dx syndromic testing solution is expected to be available soon for use in Japan with a SARS-CoV-2 Respiratory... | April 24, 2023

Two-day hybrid event to address current challenges in cancer treatment and diagnostics Uniting researchers, oncologists and data specialists... | April 18, 2023

QIAGEN N.V. to release results for Q1 2023 and hold webcast Venlo, The Netherlands, April 18, 2023 - QIAGEN N.V. announced its plans to release results for the... | April 18, 2023

Venlo, the Netherlands, April 14, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December